https://european-biotechnology.net/wp-content/uploads/2025/10/PharmaMar-SA-e1759643200994-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-10-05 05:48:41 2025-10-10 11:02:03 FDA approves atezolizumab–lurbinectedin for ES-SCLC
https://european-biotechnology.net/wp-content/uploads/2025/10/Howard-Lutnick-_United-States-secretary-of-commerce-796x1030-1.jpg
1030
796
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-10-01 21:51:16 2025-10-10 11:02:03 Pharma Tariffs: US Government backtracks
https://european-biotechnology.net/wp-content/uploads/2025/09/RezonBio-e1759258482832-1030x580-1.webp
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-09-30 18:55:50 2025-10-10 11:02:03 Biologics CDMO Rezon Bio leaves stealth mode
https://european-biotechnology.net/wp-content/uploads/2025/09/Merus-jpg-e1759169759244-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-09-29 18:16:08 2025-10-10 11:02:03 Genmab swallows Merus in US$8bn deal
https://european-biotechnology.net/wp-content/uploads/2025/09/Evaxion_199783080_tg-e1759068112780.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-09-28 14:04:08 2025-10-10 11:02:03 MSD Secures Option on EVX-B3
https://european-biotechnology.net/wp-content/uploads/2025/10/Trump-customs_1087751753_aMXQ4F7QvgiY2BGThBgXWanb2BpL96rh-e1759300939993.jpg
540
958
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-09-26 11:28:44 2025-10-01 09:02:03 Trump Targets Overseas with 100%-Tariff
https://european-biotechnology.net/wp-content/uploads/2025/09/uniqure-HQ-e1758781814446.webp
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-09-25 07:04:47 2025-09-25 07:04:47 UniQure’s stocks up after AMT-130 trial win
https://european-biotechnology.net/wp-content/uploads/2025/09/VedaBio-e1758691015919-1030x578-1.png
578
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-09-24 05:20:38 2025-09-24 05:20:38 Siemens Healthineers enters CRISPR diagnostics space
https://european-biotechnology.net/wp-content/uploads/2025/09/Revyve_team-e1758687129400.jpg
282
500
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-09-24 04:12:31 2025-09-24 04:12:31 Revyve scaling up production by €24m financing
https://european-biotechnology.net/wp-content/uploads/2025/09/assets.roche_.webp
441
784
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-09-22 19:50:07 2025-09-22 19:50:07 Roche moves obesity asset CT-388 into Phase III
Scroll to top
Scroll to top
Scroll to top
